Y. Ozguler Et Al. , "Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration," PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , vol.27, no.8, pp.894-901, 2018
Ozguler, Y. Et Al. 2018. Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , vol.27, no.8 , 894-901.
Ozguler, Y., Yazici, Y., Hatemi, G., Tascilar, K., & Yazici, H., (2018). Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , vol.27, no.8, 894-901.
Ozguler, Yeşim Et Al. "Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration," PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , vol.27, no.8, 894-901, 2018
Ozguler, Yeşim Et Al. "Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration." PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , vol.27, no.8, pp.894-901, 2018
Ozguler, Y. Et Al. (2018) . "Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration." PHARMACOEPIDEMIOLOGY AND DRUG SAFETY , vol.27, no.8, pp.894-901.
@article{article, author={Yeşim ÖZGÜLER Et Al. }, title={Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration}, journal={PHARMACOEPIDEMIOLOGY AND DRUG SAFETY}, year=2018, pages={894-901} }